The DNA of a field isolate and of a vaccine strain of canine adenovirus type 2 (CAV-2) were analysed by digestion with several restriction endonucleases. The PstI restriction fragments of the field isolate (CAV-2 Glasgow) and the vaccine strain were cloned into the plasmid pBR322. Physical maps of the two viral genomes were constructed by molecular hybridization of PstI, EcoRI, SmaI, BamHI and KpnI
INTRODUCTION
The canine adenoviruses are typical members of the Adenoviridae. They are divided into two types, based on haemagglutination inhibition and neutralization tests, canine adenovirus type 1 (CAV-1) and canine adenovirus type 2 (CAV-2). CAV-1, formerly called infectious canine hepatitis virus, replicates in vascular endothelial tissue and affects most of the major organs of the dog (Rubarth, 1947; Appel et al., 1973) . CAV-2 also referred to as canine laryngotracheitis virus was previously thought to replicate solely in the respiratory epithelium (Appel et al., 1973; Wright et al., 1974) .
Recently, however, CAV-2 has been isolated from the faeces of dogs suffering from diarrhoeal disease (Hamelin et al., 1986; Macartney et al., 1988) indicating that replication of the virus was taking place in the intestinal tract, which may implicate CAV-2 as an enteric as well as respiratory pathogen.
Despite differences in their pathogenicity and sites of replication CAV-1 and CAV-2 share common antigenic properties. This allows the use of a laboratory-attenuated strain of CAV-2 to be given as a live vaccine to protect against infectious canine hepatitis and laryngotracheitis. An attenuated strain of CAV-2 is generally preferred over CAV-1 because vaccination using the type 1 virus has frequently given rise to clinical problems, in particular corneal oedema.
In this study we have constructed recombinant plasmids which contain restriction fragments covering the entire genomes of a CAV-2 (Glasgow) field isolate and a vaccine strain. These data were used to construct cleavage maps for the two genomes for a variety of restriction enzymes. The restriction profiles of the prototype CAV-2 strains Toronto A26/61 and Manhattan are compared with those of the Glasgow strain.
Construction and analysis of recombinant plasmids. Restriction endonucleases were purchased from Pharmacia and used according to the manufacturer's instructions. Restriction enzyme digests were analysed by both agarose and polyacrylamide gel electrophoresis. CAV-2 DNA was digested with Pstl and the fragments cloned into the PstI site of pBR322. The left and right termini of the CAV genomes were cloned as blunt-ended EcoRI and bluntended Sail fragments respectively, into appropriately cut Bluescript plasmids (Stratagene). The terminal cloning was carried out using DNA which had been prepared using proteinase K, but without any sodium hydroxide or S 1 nuclease treatment. The pBR322 clones were selected on the basis of their tetracycline resistance and ampicillin sensitivity. The terminal clones in the Bluescript plasmid were initially selected as white colonies on X-galcontaining media. Recombinant plasmids were prepared from each transformant by the method of Holmes & Quigley (1981) Southern (1975) . The nitrocellulose filters were then hybridized in 50~ (v/v) formamide in 2 x SSC (0-3 ra-NaCl, 30 mM-sodium citrate) plus 200 ~tg/ml salmon sperm DNA, at 42 °C for 24 to 48 h with cloned adenoviras DlqA, ~hich had been labelled with ~zp by nick translation (Rigby et al., 1977) . Less stringent conditions were used when probing with cloned human adenovirus DNA, usually 50~ formamide and 37 °C. The filters were washed three times in 2 x SSC plus 0.1 ~ SDS, then three times in 0.2 x SSC plus 0.1 ~o SDS, dried and subjected to autoradiography.
RESULTS

Restriction enzyme analysis of CA V-2 DNA
The restriction endonuclease cleavage patterns obtained by digestion of CAV-2 DNA with
BamHI, EcoRI, KpnI, PstI, SalI and Sinai are shown in Fig. 1 . The fragment lengths calculated from the electrophoretic mobilities are given in Table 1 . The fragmentation patterns of the field isolate (Glasgow strain) and the vaccine strain (Vaxitas) are essentially the same; however, some differences do occur and these will be described and discussed later. Digestion of CAV-2
Glasgow DNA with PstI yields 11 fragments, two of these fragments (C and D) comigrate at 4-4 Molecular cloning of CA V-2 Pstl fragments Digestion of CAV-2 with PstI gives 11 fragments (Fig. 1) ranging in size from 6.0 kbp to 0.2 kbp. This number of fragments and range of sizes make them amenable to cloning in a plasmid vector. Nine of the 11 PstI fragments were cloned into the PstI site of pBR322. The two remaining fragments C and H (in Glasgow strain) and C and G (Vaxitas strain) were not initially cloned as PstI fragments but were instead cloned as Sali blunt-ended (Sail B) and EcoRI blunt-ended (EcoRI C) fragments. The terminal PstI fragments were subcloned from these.
Recombinant plasmids were digested with PstI and the electrophoretic mobility of the inserted CAV-2 DNA was compared with PstI-cleaved CAV-2 DNA. The recombinant plasmids were characterized further by hybridization against Southern transfers of PstI-digested CAV-2 DNA (Fig. 2) ; all the PstI-cloned fragments hybridized with a single PstI fragment in these experiments, but the cloned termini showed the characteristic homology due to the terminal repeats. In the case of the PstI I, J and K cloned fragments, they were used to probe PstI-digested DNA which had been separated on 2 ~ agarose in order to show hybridization to themselves only.
Physical maps of CA II-2 DNA The maps shown in Fig. 3 were constructed using the data from molecular hybridization experiments (Fig. 2) and restriction fragment sizes (Table 1 ). The SmaI sites at map units 0-75 and 99.25, giving rise to SmaI fragments H and I, were also located by sequence analysis of the CAV terminal fragments (unpublished data). Hybridization against small DNA fragments (PstI I, J, K and SmaI H and I) was performed on Southern transfers from 2~ agarose.
The terminal PstI fragments were identified as fragments C and H of the Glasgow strain, and C and G of Vaxitas. The terminal fragments of CAV-2 Vaxitas show considerable heterogeneity (Fig. 1) , which is most clearly visible with EcoRI C and Sail B. In constructing the restriction map (Fig. 3) the size of the most predominant species was taken. Cross-hybridization was observed between the terminal fragments ( Fig. 2 ) which is probably due to the homologous inverted terminal repeats found in all adenoviruses (Tooze, 1981; Sussenbach, 1984) .
The order of BamHI fragments within PstI B (Glasgow) was determined by KpnI and BamHI double digests of the cloned PstI B fragment (data not shown).
Data from the molecular hybridization experiments was confirmed by restriction endonuclease digestion of the CAV-2 recombinant plasmids; for example the clone of PstI G was shown to be cut by EcoRI, whereas no other cloned fragment has a site for EcoRI. From Fig. 3 it can clearly be seen that the restriction maps of the field isolate and vaccine strain are very similar, but some differences do occur in the terminal fragments and in the PstI D fragment of Vaxitas. The right terminal PstI fragment (fragment H) of Glasgow strain is 1.3 kbp, whereas its counterpart in Vaxitas is 3.3 kbp. The nature and exact point(s) of insertion of the additional DNA sequences in the vaccine strain is under investigation and initial studies indicate that the point of insertion is within 500 bp of the terminus. Additional DNA sequences are also present at the left terminus of Vaxitas, the terminal PstI fragment measuring 4.7 kbp compared with 4-4 kbp in the Glasgow strain.
Comparison of physical maps of CA 1I-2 Glasgow and Vaxitas DNA
The PstI D fragment of CAV-2 Glasgow (4.4 kbp) is present in Vaxitas as a 4.1 kbp fragment. The deletion which has occurred in the vaccine strain removes a KpnI site, resulting in the loss of the 0-6 kbp KpnI fragment.
The restriction profiles of CAV-2 Toronto (A26/61) and Manhattan appear identical to the Glasgow isolate in all the restriction enzyme digests apart from the HpalI digest. 
Determination of genome orientation
The physical maps of the CAV genomes were orientated with respect to human adenovirus genomes by probing Southern transfers of CAV (Glasgow) D N A with cloned fragments of human adenovirus (Ad) types 5 and 12. The BglII C fragment of Ad5 (map units 45.3 to 60.2) carries hexon-coding sequences, and this fragment was used to probe the CAV genome (Fig. 4b) . Two Pst! fragments (E and F) and two KpnI fragments (C and E) hybridize to this Ad5 clone. A SacI/BgllI subclone of this fragment (map units 56.6 to 60.2) only hybridizes to the PstI F and KpnI E fragments (data not shown). The cloned EcoRI C fragment of Adl2 (map units 0 to 16.2) was shown to hybridize to BamHI A and EcoRI C. These data indicate that the orientation of the CAV genome is as shown in Fig. 3 .
DISCUSSION
In this paper we have described the construction of recombinant plasmids containing PstI restriction fragments of the DNA from two strains of CAV-2. These recombinant plasmids were used to construct BamHI, EcoRI, KpnI, PstI, SalI and Sinai cleavage maps of CAV-2 DNA.
These data show that the first U.K. isolate of CAV-2 (Glasgow strain) has the same restriction enzyme profile as two prototype CAV-2 strains, Toronto A26/61 and Manhattan. The cleavage maps of the CAV-2 Glasgow strain and a vaccine strain of CAV-2 (Vaxitas), which was originally derived from the Manhattan strain, are essentially the same. The differences which do exist between Vaxitas and the field isolates, i.e. the additional DNA at an advantage over the wild-type helper virus in mixed infections. Analysis of virulent and vaccine strains of bovine herpesvirus type 1 (BHV-1) revealed at 14 bp sequence at the left end of the genome repeated between eight and 38 times (Hammerschmidt et al., 1986) .
Illegitimate recombination and aberrant replication have been proposed as mechanisms by which reiterated DNA sequences arise (Smith, 1976) . Subsequent homologous recombination could increase the number of copies of the repeated sequence. Selection of variant genomes would be based on replication and encapsidation efficiency. It is interesting to note that the repeated sequences in BHV-1, Ad3 and possibly CAV are in regions of the genomes associated with viral DNA replication. Furthermore the growth characteristics of CAV-2 Vaxitas and other vaccine strains of CAV suggest that in these strains DNA replication is impaired.
Work is now in progress to define more precisely the nature and location of the additional DNA sequences in the CAV vaccine strains, and to investigate the effect they have on DNA replication and gene expression.
The Glasgow strain of CAV-2 was isolated from the faeces of a young dog with diarrhoeal disease (Macartney et al., 1988) , which suggests that viral replication may have been taking place in the intestinal tract, an unusual site of replication for a virus associated with respiratory disease (Koptopoulos & Cornwell, 1981) . The apparent ability of the virus to replicate in the gut does not appear to be accompanied by any major changes in the restriction enzyme cleavage patterns. However, some minor differences were observed in the HpalI restriction profiles of CAV-2 Glasgow and the two prototype strains. It is hoped that further work currently being undertaken will explain the relevance, if any, of these minor differences between the Glasgow and prototypic strains of CAV-2.
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